With a clear strategic direction in place and over 25 years of experience in the pharmaceutical industry, the CEO, Mr. Basel is poised to continue the transformational journey and lead the company towards its vision of providing health solutions regionally and globally, while ensuring world-class care remains at the very heart of Julphar.

experience in the industry working with top global and regional companies across the MENA region, Mr. Basel is a seasoned leader with rich exposure to in the field of pharmaceutical marketing and multi-site manufacturing and strategy development in the field of vaccines and biological medicines, business development and distribution. His proven track record to drive business transformation and expansion with a hands-on approach will ensure Julphar’s mission to delivering greater impact across all the markets we serve globally.

Mr. Basel was CEO for Tabuk Pharmaceuticals, where he was instrumental in transforming the business, leading the company’s substantial profitability expansion in addition to establishing key partnerships. Mr. Basel also held several leadership positions at Hikma Pharmaceuticals, serving across various functions and geographies over a 15-year period. During his tenure, he led the company’s branded strategy formulation and execution in the MENA region after leading Hikma’s full operations in the GCC and the Levant. In addition, he also served as an advisor and Board Member for several pharmaceutical entities in Saudi Arabia, Egypt, Jordan, Sudan, Iraq and Lebanon.

Mr. Basel holds a Bachelor’s degree in Biological Sciences from University of Jordan and an MBA from American University of Beirut.